Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: A systematic review and meta-analysis

Current Pharmaceutical Biotechnology

Volumn 13, Issue 3, 2012, Pages 464-470

  Kolibianakis, E M ^a   Venetis, C A ^a   Bontis, J ^a   Tarlatzis, B C ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Clinical pregnancy; GnRH antagonists; In vitro fertilization; Meta analysis; Premature luteinization; Progesterone elevation

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

DRUG EFFECT; ESTRADIOL BLOOD LEVEL; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; META ANALYSIS; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; REVIEW; SYSTEMATIC REVIEW;

CHORIONIC GONADOTROPIN; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROGESTERONE;

EID: 84857735230     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112799361927     Document Type: Review

References (13)

1. Kolibianakis, E. M.; Venetis, C. A.; Tarlatzis, B. C. Role of the endocrine profile for the achievement of pregnancy with IVF. Reprod. Biomed. Online, 2009, 18 (Suppl 2), 37-43.
2. Venetis, C. A.; Kolibianakis, E. M.; Papanikolaou, E.; Bontis, J.; Devroey, P.; Tarlatzis, B. C. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum. Reprod. Update, 2007, 13 (4), 343-55.
3. Bosch, E.; Valencia, I.; Escudero, E.; Crespo, J.; Simon, C.; Remohi, J.; Pellicer, A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil. Steril., 2003, 80(6), 1444-1449.
4. Papanikolaou, E. G.; Kolibianakis, E. M.; Pozzobon, C.; Tank, P.; Tournaye, H.; Bourgain, C.; Van Steirteghem, A.; Devroey, P. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil. Steril., 2009, 91(3), 949-952.
5. Seow, K. M.; Lin, Y. H.; Huang, L. W.; Hsieh, B. C.; Huang, S. C.; Chen, C. Y.; Chen, P. H.; Tzeng, C. R.; Hwang, J. L. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles. Gynecol. Endocrinol., 2007, 23(6), 338-342.
6. Eleno, I.; Matallin Evangelio, P.; Gavila, N.; Alfayate, R.; Mauri, M.; Cremades, N.; Martinez Escoriza, J. C. Predictive value of plasma progesterone on hCG administration day in the outcome of IVF-ET cyles. Revista Iberoamericana de Fertilidad y Reproduccion Humana, 2006, 23(4), 257-264.
7. Bosch, E., Comment on: is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. By Venetis et al (2007). Hum. Reprod. Update, 2008, 14 (2), 194-195; author reply 195-196.
8. Ubaldi, F.; Albano, C.; Peukert, M.; Riethmuller-Winzen, H.; Camus, M.; Smitz, J.; Van Steirteghem, A.; Devroey, P. Subtle progesterone rise after the administration of the gonadotrophinreleasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum. Reprod., 1996, 11(7), 1405-1407.
9. Sohn, S. H.; Penzias, A. S.; Emmi, A. M.; Dubey, A. K.; Layman, L. C.; Reindollar, R. H.; DeCherney, A. H. Administration of progesterone before oocyte retrieval negatively affects the implantation rate. Fertil. Steril., 1999, 71 (1), 11-14.
10. Griesinger, G.; von Otte, S.; Schroer, A.; Ludwig, A. K.; Diedrich, K.; Al-Hasani, S.; Schultze-Mosgau, A. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Hum. Reprod., 2007, 22 (5), 1348-1352.
11. Eldar-Geva, T.; Margalioth, E. J.; Brooks, B.; Algur, N.; Zylber- Haran, E.; Diamant, Y. Z. The origin of serum progesterone during the follicular phase of menotropin-stimulated cycles. Hum. Reprod., 1998, 13 (1), 9-14.
12. Smitz, J.; Andersen, A. N.; Devroey, P.; Arce, J. C. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. Hum. Reprod., 2007, 22 (3), 676-687.
13. Andersen, A. N.; Devroey, P.; Arce, J. C. Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum. Reprod., 2006, 21(12), 3217-3227.